Abstract:Autosomal dominant lateral temporal epilepsy (ADLTE) is an inherited syndrome caused by mutations in the leucine-rich glioma inactivated 1 (LGI1) gene. It is known that glutamatergic transmission is altered in LGI1 mutant mice, and seizures can be reduced by restoring LGI1 function. Yet, the mechanism underlying ADLTE is unclear. Here, we propose that seizures in male LGI1-/- mice are due to nonsynaptic epileptiform activity in cortical neurons. We examined the intrinsic excitability of pyramidal neurons in the temporal cortex of male LGI1-/- mice and found that the voltage-gated K+ channel Kv1.2 was significantly downregulated. We also found that cytosolic phospholipase A2 (cPLA2)-cyclooxygenase 2 (Cox2) signaling was enhanced in LGI1-/- mice. Interestingly, Cox2 inhibition effectively restored the dysregulated Kv1.2 and reduced the intrinsic excitability of pyramidal neurons. Moreover, in vivo injection of celecoxib, an FDA-approved nonsteroidal anti-inflammatory drug, rescued the defective Kv1.2 (an ∼1.9-fold increase), thereby alleviating the seizure susceptibility and extending the life of LGI1-/- mice by 5 d. In summary, we conclude that LGI1 deficiency dysregulates cPLA2-Cox2 signaling to cause hyperexcitability of cortical pyramidal neurons, and celecoxib is a potential agent to manage human ADLTE.SIGNIFICANCE STATEMENT Haploinsufficiency of the leucine-rich glioma inactivated 1 (LGI1) gene is the major pathogenic basis for ADLTE, an inherited syndrome with no cure to date. Existing studies suggest that altered glutamatergic transmission in the hippocampus causes this disease, but the data are paradoxical. We demonstrate that the loss of LGI1 decreases Kv1.2 expression, enhances intrinsic excitability, and thereby causes epilepsy. Interestingly, for the first time, we show that an FDA-approved drug, celecoxib, rescues the Kv1.2 defect and alleviates seizure susceptibility in LGI1-/- mice, as well as improving their survival. Thus, we suggest that celecoxib is a promising drug for the treatment of ADLTE patients.

Autosomal dominant lateral temporal epilepsy in a family exhibiting a rare heterozygous mutation and deletion in the leucine-rich glioma inactivated 1 gene

[Clinical characteristics and LGI1 gene mutation analysis on an autosomal dominant lateral temporal lobe epilepsy]

A Patient-Derived Mutation of Epilepsy-Linked LGI1 Increases Seizure Susceptibility Through Regulating Kv1.1.

Familial mesial temporal lobe epilepsy phenotype is associated with novel LGI1 variants: A report of two families

A novel <i>Lgi1</i> mutation causes white matter abnormalities and impairs motor coordination in mice

Leber's Hereditary Optic Neuropathy-Associated ND6 14484T > C Mutation Caused Pleiotropic Effects on the Complex I, RNA Homeostasis, Apoptosis and Mitophagy.

Autosomal dominant epilepsy with auditory features: a new LGI1 family including a phenocopy with cortical dysplasia

Celecoxib Ameliorates Seizure Susceptibility in Autosomal Dominant Lateral Temporal Epilepsy.

The LGI1 protein: molecular structure, physiological functions and disruption-related seizures

Identification of A Kir3.4 Mutation in Congenital Long Qt Syndrome

A Case of Megalencephalic Leukoencephalopathy with Subcortical Cysts Type 1 Was Identified with a Novel Compound Heterozygous Alteration (c.135delc; C.423+2dupt) in China

Molecular typing of familial temporal lobe epilepsy

A Novel Splice Mutation of HERG in a Chinese Family with Long QT Syndrome.

Lgi1 Null Mutant Mice Exhibit Myoclonic Seizures and Ca1 Neuronal Hyperexcitability

Association of LONP1 gene with epilepsy and the sub-regional effect

The Study of Genetic Susceptibility and Mitochondrial Dysfunction in Mesial Temporal Lobe Epilepsy

Autosomal dominant lateral temporal lobe epilepsy associated with a novel reelin mutation

A Novel Loss-of-Function Mutation in the NPRL3 Gene Identified in Chinese Familial Focal Epilepsy with Variable Foci

Case Report: A Homozygous Mutation (p.Y62X) of Phospholipase D3 May Lead to a New Leukoencephalopathy Syndrome

Leber Hereditary Optic Neuropathy and Dystonia Overlapping Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes Due to M.14459g>a Mutation

A Founder Mutation in VPS11 Causes an Autosomal Recessive Leukoencephalopathy Linked to Autophagic Defects